Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes

US Patent 8383812 · Granted Feb 26, 2013

Estimated economic value: $45,643,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic PAD4 inhibitors2025
Isoxazole carboxylic acids as LPA antagonists2025
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof2025
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists2025
Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-t2024
Non-chromatographic purification of macrocyclic peptides by a resin catch and re2024
Modulating Nudix homology domain (NHD) with nicotinamide mononucleotide analogs 2024
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists2023
Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods fo2023
Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists2023
Indole and azaindole inhibitors of pad enzymes2022
Non-chromatographic purification of macrocyclic peptides by a resin catch and re2022